Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Robert D. Terry, Eliezer Masliah, David P. Salmon et al. · Annals of Neurology · 1991 · 4.4K citations

Medicine, Neurology, Neuroscience +17

Diagnosis of Alzheimer's Disease

Zaven S. Khachaturian · Archives of Neurology · 1985 · 2.5K citations

Medicine, Neurology, Psychiatry +13

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

Steven T. DeKosky, Stephen W. Scheff · Annals of Neurology · 1990 · 2.4K citations

Medicine, Neurology, Neuroscience +17

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Iain L. Campbell, Carmela R. Abraham, Eliezer Masliah et al. · Proceedings of the National Academy of Sciences · 1993 · 1K citations

Life Sciences, Neurobiology, Neuroscience +17